Moreover, IFNγ signatures (CXCL10, CXCL9, IDO1, IFNG, and STAT1) and myeloid lineage phenotypic and functional markers (CD14, CD163, CD33, and CD68) were also significantly increased in melanoma patients with high ETV7 (Figures 7G, H). This evidence concerns the gene CXCL9 and melanoma.